PMVP
PMVP
NASDAQ · Biotechnology

Pmv Pharmaceuticals Inc

$1.34
+0.05 (+3.88%)
As of Jun 30, 10:39 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +419.4% upside
Low Target $5.52
Average Target $6.96
High Target $10.50
Current Price $1.34
Current
$1.34
Target
$6.96
$5.52 $6.96 avg $10.50
Scenario Analysis
Bear Case
$5.52
311.9%
Low target
Base Case
$6.96
+419.4%
Avg target
Bull Case
$10.50
+683.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$1.88
-28.7% from high
52-Week Low
$0.96
+39.0% from low
Target vs 52W High
$6.96
+270.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%